0001209191-20-064062.txt : 20201217 0001209191-20-064062.hdr.sgml : 20201217 20201217163212 ACCESSION NUMBER: 0001209191-20-064062 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201215 FILED AS OF DATE: 20201217 DATE AS OF CHANGE: 20201217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Quimi Daphne CENTRAL INDEX KEY: 0001543031 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33497 FILM NUMBER: 201396480 MAIL ADDRESS: STREET 1: C/O AMICUS THERAPEUTICS, INC. STREET 2: 1 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMICUS THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001178879 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 200422823 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 BUSINESS PHONE: (609) 662-2000 MAIL ADDRESS: STREET 1: 1 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 FORMER COMPANY: FORMER CONFORMED NAME: AMICUS THERAPEUTICS INC DATE OF NAME CHANGE: 20020729 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-15 0 0001178879 AMICUS THERAPEUTICS, INC. FOLD 0001543031 Quimi Daphne C/O AMICUS THERAPEUTICS 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 0 1 0 0 Chief Financial Officer Common Stock 2020-12-15 4 M 0 11500 2.94 A 229679 D Common Stock 2020-12-15 4 M 0 7550 4.38 A 237229 D Common Stock 2020-12-15 4 M 0 4379 3.53 A 241608 D Common Stock 2020-12-15 4 M 0 6892 2.45 A 248500 D Common Stock 2020-12-15 4 F 0 4156 23.86 D 244344 D Stock Options (right to buy) 2.94 2020-12-15 4 M 0 11500 0.00 D 2024-06-26 Common Stock 11500 21628 D Stock Options (right to buy) 4.38 2020-12-15 4 M 0 7550 0.00 D 2022-06-04 Common Stock 7550 0 D Stock Options (right to buy) 3.53 2020-12-15 4 M 0 4379 0.00 D 2023-01-28 Common Stock 4379 0 D Stock Options (right to buy) 2.45 2020-12-15 4 M 0 6892 0.00 D 2024-01-03 Common Stock 6892 0 D Represents shares swapped to cover the strike price of the options exercised. All of the options were fully vested and exercisable as of the transaction date. /s/ Christian Formica, Attorney-in-Fact 2020-12-17